23 May 2013
Keywords: qlt, six-month, eligard, approved, germany, usa, subsidiary
Article | 11 December 2006
QLT USA, a subsidiary of Canadian biopharmaceutical firm QLT, says that the German regulatory authority has approved the six-month formulation
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 December 2006
4 December 2006
18 December 2006
© 2013 thepharmaletter.com